(Q42542916)

English

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers

scientific article published on 26 July 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

amyotrophic lateral sclerosis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

enterotoxigenic Escherichia coli

1 reference

based on heuristic

inferred from title

Escherichia coli

object named as

Escherichia coli

1 reference

based on heuristic

inferred from title

author name string

Carpenter CM

1

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Hall ER

2

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Randall R

3

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

McKenzie R

4

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Cassels F

5

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Diaz N

6

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Thomas N

7

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Bedford P

8

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Darsley M

9

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Gewert C

10

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Howard C

11

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sack RB

12

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sack DA

13

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Chang HS

14

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Gomes G

15

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Bourgeois AL

16

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

language of work or name

0 references

publication date

26 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

24

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

3709-3718

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Epidemiology of diarrhoeal disease: implications for control by vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Mucosal immunity: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Pilot study of phoP/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Rapid diagnosis of active tuberculosis by detecting antibodies from lymphocyte secretions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Construction and characterization of genetically defined aro omp mutants of enterotoxigenic Escherichia coli and preliminary studies of safety and immunogenicity in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Enteral immunization and challenge of volunteers given enterotoxigenic E. coli CFA/II encapsulated in biodegradable microspheres

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Lack of prophylactic efficacy of an enteric-coated bovine hyperimmune milk product against enterotoxigenic Escherichia coli challenge administered during a standard meal

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Identification and characterization of hydrophobic Escherichia coli virulence proteins by liquid chromatography-electrospray ionization mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Antibody responses after immunization with killed oral cholera vaccines during the 1985 vaccine field trial in Bangladesh

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Europium-labelled streptavidin as a highly sensitive universal label. Indirect time-resolved immunofluorometry of FSH and TSH

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Antibody-secreting cells in the evaluation of the immunogenicity of an oral vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Safety and immunogenicity of an oral, inactivated enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Bangladeshi adults and children

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic escherichia coli-cholera toxin B subunit vaccine in Israeli young adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Oral, inactivated, whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine: results of the initial evaluation in children. PRIDE Study Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Safety and immunogenicity of an oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Egyptian adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Antibody-secreting cells in human peripheral blood after oral immunization with an inactivated enterotoxigenic Escherichia coli vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

Coli surface antigens 1 and 3 of colonization factor antigen II-positive enterotoxigenic Escherichia coli: morphology, purification, and immune responses in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Saliva, breast milk, and serum antibody responses as indirect measures of intestinal immunity after oral cholera vaccination or natural disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.07.022

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.07.022

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42542916&oldid=1961270175"